Venlafaxine: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz No edit summary |
||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
In [[medicine]] and [[ | {{TOC|right}} | ||
In [[medicine]] and [[neuropharmacology]], '''venlafaxine''' is a [[second generation antidepressant]] that has unusual chemistry: it inhibits the reuptake of several [[neurotransmitter]]s depending on dose. | |||
==History== | ==History== | ||
Revision as of 21:37, 21 August 2010
In medicine and neuropharmacology, venlafaxine is a second generation antidepressant that has unusual chemistry: it inhibits the reuptake of several neurotransmitters depending on dose.
History
Effexor brand of venlafaxine was approved by the Food and Drug Administration in the United States with a New Drug Application (NDA) in 1993.[1] A generic version was approved with a NDA in 2008.[2]
Generic versions of the time-release form are also available.
Pharmacology
Administration
Distribution
Metabolism
Excretion
Toxicity
External links
The most up-to-date information about Venlafaxine and other drugs can be found at the following sites.
- Venlafaxine - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Venlafaxine - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Venlafaxine - Detailed information from DrugBank.
References
- ↑ Anonymous. Drugs@FDA for FDA Application No. 020151. U S Food and Drug Administration
- ↑ Anonymous. Drugs@FDA for FDA Application No. 022104. U S Food and Drug Administration